Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - BioScrip, Inc.bios-ex321x2016033110xq.htm
EX-31.2 - EXHIBIT 31.2 - BioScrip, Inc.bios-ex312x2016033110xq.htm
EX-31.1 - EXHIBIT 31.1 - BioScrip, Inc.bios-ex311x2016033110xq.htm
10-Q - 10-Q - BioScrip, Inc.bios-20160331x10q.htm


EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BioScrip, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey M. Kreger, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)     The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 6, 2016



/s/ Jeffrey M. Kreger______________________
Jeffrey M. Kreger, Chief Financial Officer,
Treasurer and Principal Financial Officer